Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep ...

The statement also notably included a "first-line" call out for icosapent ethyl , a novel agent approved in December 2019 for routine use in U.S. patients, including those with CAD and T2DM as ...

Compared to placebo, canagliflozin reduced the risk of the composite primary endpoint (cardiovascular mortality, nonfatal MI, nonfatal stroke) by 14% (HR: 0.86; 95% CI: 0.75-0.97).

Populations of African descent are at the forefront of the worldwide epidemic of type 2 diabetes mellitus (T2DM). Here, Anne Sumner and colleagues discuss issues related to the diagnosis and ...

ROCKVILLE, MD and SHENZHEN, CHINA, - (NewMediaWire) - June 21, 2024 - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multi ...

METHODOLOGY: Investigators analyzed data from clinical and laboratory tests, FibroScan, and liver ultrasonography for 154 patients (average age, 51 years; 59.7% men; 42.9% with T2DM) with MASLD in ...

Out of the 100 individuals diagnosed with T2DM, ultrasonography confirmed NAFLD in 50 patients, who were categorized as Group A, while the remaining 50 patients without fatty liver comprised Group ...

CAD: More Common in Patients with T2DM and Heterozygous Familial Hypercholesterolemia? —That was the question at the center of a Chinese study that assessed patients with heterozygous familial ...

Conclusions: T2DM patients with established CVD or CVD risk factors are at significant risk for mortality and CVD events. They incur high healthcare utilization and costs, ...